首页> 外国专利> NOVEL LACTOBACILLUS LIVING BODY ACTIVATING LACTOBACILLUS PREPARATION AND PREVENTIVE OR THERAPEUTIC AGENT AGAINST LIVING BODY INFECTION

NOVEL LACTOBACILLUS LIVING BODY ACTIVATING LACTOBACILLUS PREPARATION AND PREVENTIVE OR THERAPEUTIC AGENT AGAINST LIVING BODY INFECTION

机译:活菌的新型乳酸菌活体乳酸菌的制备及预防或治疗活体感染的治疗剂

摘要

There has been effort to develop a lactobacillus that would be useful as a probiotic, and to develop a lactobacillus which would colonize and proliferate in lesions of infection, eliminating the causal bacteria. This problem was resolved by developing a Lactobacillus casei species having the following key properties. (1) The species can be grown in the presence of any of one to four amino acids as a nitrogen source necessary for growth. (2) When a growth-promoting culture medium, is inoculated with the species and escherichia coli in the same court and subjected to anaerobic mixed culturing at 37°C the final count of lactobacilli is 50% or more of the coliform count. (3) Upon cultivation in an appropriate culture medium, the final pH value is 4.0 or below, and the highest acidity is 1.5% or more (4) the species is resistant to 5% bile salts. (5) The species produces an antibiotic
机译:已经努力开发可用作益生菌的乳杆菌,并开发在感染病灶中定殖和增殖,消除病原细菌的乳杆菌。通过开发具有以下关键特性的干酪乳杆菌种解决了该问题。 (1)该物种可以在1-4个氨基酸中的任何一种作为生长必需的氮源的存在下生长。 (2)当在同一场所用种和大肠杆菌接种促进生长的培养基并在37℃进行厌氧混合培养时,乳酸杆菌的最终计数为大肠菌计数的50%以上。 (3)在适当的培养基上培养后,最终的pH值为4.0或更低,最高酸度为1.5%或更高(4)该物种对5%的胆汁盐具有抗性。 (5)该物种产生抗生素

著录项

  • 公开/公告号IN2006MN00214A

    专利类型

  • 公开/公告日2007-06-15

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN214/MUMNP/2006

  • 申请日2006-02-21

  • 分类号A61K31/192;A61K31/375;A61K33/26;A61P43/00;A61P31/04;A61K35/74;C12R1/245;A61P1/02;A01P3/00;A01N63/02;A61K31/235;A01N63/00;A61K31/19;C12N1/20;

  • 国家 IN

  • 入库时间 2022-08-21 20:57:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号